Search Results - "Khushalani, N."

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy by Ahmed, K.A., Abuodeh, Y.A., Echevarria, M.I., Arrington, J.A., Stallworth, D.G., Hogue, C., Naghavi, A.O., Kim, S., Kim, Y., Patel, B.G., Sarangkasiri, S., Johnstone, P.A.S., Sahebjam, S., Khushalani, N.I., Forsyth, P.A., Harrison, L.B., Yu, M., Etame, A.B., Caudell, J.J.

“…Novel targeted and immunotherapeutic agents have revolutionized systemic melanoma management. We note differing rates of distant brain control as well as…”
Get full text

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis by Hamid, O., Ribas, A., Daud, A., Butler, M.O., Carlino, M.S., Hwu, W.-J., Long, G.V., Ancell, K., Hodi, F.S., Khushalani, N.I., Blank, C.U., Loquai, C., Lin, J., Diede, S.J., Robert, C.

Get full text

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) by Moschos, S.J., Eroglu, Z., Khushalani, N.I., Kendra, K.L., Ansstas, G., In, G.K., Wang, P., Liu, G., Collichio, F.A., Arrowood, C.C., Reed, J.E., Garrett-Mead, N., Thomas, N.E., Ollila, D.W., Ivy, S.P., Ivanova, A., Dees, E.C., Abbruzzese, J.L.

Get full text

Detection of a possible case of Pulmonary Tumour Thromboembolism by endobronchial ultrasound by Dhillon, S.S., Berim, I.G., Khushalani, N., Gannon, J.

Get full text

6517 POSTER Sunitinib and Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma (HCC)- Final Results of a Phase 2 Trial by Iyer, R, Fetterly, G, Groman, A, Hutson, A, Khushalani, N, Mohile, S, Ashton, E, Litwin, A, Grande, C, Tomaszewski, G

Get full text

Detection of a possible case of pulmonary tumour thromboembolism by endobronchial ultrasound by Dhillon, S S, Berim, I G, Khushalani, N, Gannon, J

Get full text

Cancer of Unknown Primary Presenting with Liver Metastasis: A Cost, Time to Treatment and Outcome Analysis by Saif Ur Rehman, S, Ahluwalia, M.S, Mashtare, T.L, Spritzer, M, Kim, F.J, Khushalani, N, Iyer, R

Get full text

Renal Function following Abdominal Chemoradiotherapy for Gastrointestinal Malignancies in Elderly Patients by Salerno May, K, Fakih, M, Khushalani, N, Chandrasekhar, R, Wilding, G, Park, L, Flaherty, L, Russo, R, Iyer, R, Yang, G

Get full text

Respiratory syncytial virus infection in the late bone marrow transplant period : report of three cases and review by KHUSHALANI, N. I, BAKRI, F. G, CZUCZMAN, M. S, SEGAL, B. H, MCCARTHY, P. L, WENTLING, D, BROWN, K, MOHR, A, ANDERSON, B, KEESLER, C, BALL, D, BERNSTEIN, Z. P, BERNSTEIN, S. H

“…Respiratory syncytial virus (RSV) infection is an important cause of respiratory mortality in immunosuppressed patients, including bone marrow transplant (BMT)…”
Get full text

Expression of Genes Related to Activity of Oxaliplatin and 5-Fluorouracil in Endoscopic Biopsies of Primary Esophageal Cancer in Patients Receiving Oxaliplatin, 5-Flourouracil and Radiation: Characterization and Exploratory Analysis with Survival by Leichman, L., Lawrence, D., Leichman, C.G., Nava, H., Nava, E., Proulx, G., Clark, K., Khushalani, N.I., Berdzik, J., Greco, W., Smith, P., Creaven, P.J., Kepner, J.L., Javle, M.M., Pendyala, L.

“…With a goal of identifying relations between gene expression and response (mucosal or pathological) or survival in esophageal cancer patients (stages II to IV)…”
Get full text

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma by Migden, Michael R, Rischin, Danny, Schmults, Chrysalyne D, Guminski, Alexander, Hauschild, Axel, Lewis, Karl D, Chung, Christine H, Hernandez-Aya, Leonel, Lim, Annette M, Chang, Anne Lynn S, Rabinowits, Guilherme, Thai, Alesha A, Dunn, Lara A, Hughes, Brett G.M, Khushalani, Nikhil I, Modi, Badri, Schadendorf, Dirk, Gao, Bo, Seebach, Frank, Li, Siyu, Li, Jingjin, Mathias, Melissa, Booth, Jocelyn, Mohan, Kosalai, Stankevich, Elizabeth, Babiker, Hani M, Brana, Irene, Gil-Martin, Marta, Homsi, Jade, Johnson, Melissa L, Moreno, Victor, Niu, Jiaxin, Owonikoko, Taofeek K, Papadopoulos, Kyriakos P, Yancopoulos, George D, Lowy, Israel, Fury, Matthew G

“…Among patients with advanced cutaneous squamous-cell carcinoma, the PD-1 inhibitor cemiplimab induced a response in approximately half the patients and was…”
Get full text

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma by Gross, Neil D., Miller, David M., Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo B., Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer H., Hughes, Brett G.M., Schadendorf, Dirk, Patel, Vishal A., Homsi, Jade, Taube, Janis M., Lim, Annette M., Ferrarotto, Renata, Kaufman, Howard L., Seebach, Frank, Lowy, Israel, Yoo, Suk-Young, Mathias, Melissa, Fenech, Keilah, Han, Hyunsil, Fury, Matthew G., Rischin, Danny

“…A phase 2, multicenter study showed that four doses of neoadjuvant cemiplimab (anti–PD-1 antibody) led to a pathological complete response in 51% of patients…”
Get full text

1155TiP Pan-tumour study CheckMate 8TT for long-term follow-up of cancer survivors who have participated in trials investigating nivolumab by Denlinger, C., Lu, G., Nair, S., Kalinka, E., Hosein, F., Li, J., Khushalani, N.

Get full text

6603 A phase II study of erlotinib in patients (pts) with advanced pancreatic cancer (APC) who are refractory to gemcitabine (G) by Iyer, R, Khushalani, N, Tan, W, Litwin, A, LeVea, C, Hutson, A, Tucker, C, Ma, W, Fakih, M, Adjei, A

Get full text

S-phase modulation by irinotecan : pilot studies in advanced solid tumors by RAMNATH, N, KHUSHALANI, N, JAVLE, M. M, BERDZIK, J, CREAVEN, P. J, RUSTUM, Y. M, TOTH, K, LITWIN, A. M, INTENGAN, M. E, SLOCUM, H. K, PENDYALA, L, SMITH, P. F, STEWART, C. C, HOFFMAN, J. L

“…Two studies of irinotecan (CPT-11) followed 24 h later by an antimetabolite were conducted. The objectives of the studies were: (1) to determine whether the…”
Get full text

P14.26 Leptomeningeal Disease Secondary to Melanoma: Diagnosis, Treatment, and Outcomes at a Single Institution between 2013 and 2019 by Pina, Y, Mokhtari, S, Evernden, B R, Tran, N D, Smalley, I, Khushalani, N I, Law, V W, Puskas, J A, Caceres, G, Smalley, K, Peguero, E, Forsyth, P

“…Abstract BACKGROUND Leptomeningeal disease (LMD) is devastating with a median survival of only 8–10 weeks. LMD affects approximately 5% to 25% of melanoma…”
Get full text

1321PA phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary report by Kim, S, Khushalani, N I, Eroglu, Z, Russell, J, Wuthrick, E, Caudell, J, Harrison, L, Aoki, M, Shah, H, Blakaj, D, Markowitz, J, Chen, D-T, Messina, J, Rose, T, Tsai, K, Brohl, A S

“…Abstract Background MCC is an aggressive cutaneous malignancy. Though checkpoint inhibitor therapy has dramatically improved the treatment landscape, outcome…”
Get full text

1248PDEfficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis by Hamid, O, Ribas, A, Daud, A, Butler, M O, Carlino, M S, Hwu, W-J, Long, G V, Ancell, K, Hodi, F S, Khushalani, N I, Blank, C U, Loquai, C, Lin, J, Diede, S J, Robert, C

Get full text

1318PPhase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC) by Rischin, D, Lim, A M, Schmults, C D, Khushalani, N I, Hughes, B G, Schadendorf, D, Dunn, L A, Chang, A L S, Hauschild, A, Ulrich, C, Eigentler, T, Migden, M R, Pavlick, A C, Geiger, J, Stankevich, E, Li, S, Lowy, I, Fury, M G, Guminski, A

“…Abstract Background Cemiplimab-rwlc is the only US FDA-approved treatment for patients (pts) with advanced CSCC. The primary analysis of a weight-based regimen…”
Get full text

1268PNCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) by Moschos, S J, Eroglu, Z, Khushalani, N I, Kendra, K L, Ansstas, G, In, G K, Wang, P, Liu, G, Collichio, F A, Arrowood, C C, Reed, J E, Garrett-Mead, N, Thomas, N E, Ollila, D W, Ivy, S P, Ivanova, A, Dees, E C, Abbruzzese, J L

Get full text